Somnum Pharma, Inc.

NEW YORK, NY · Founded 2024 · Biotech · Private

Small molecule therapeutics for sleep and circadian disorders

Claim this profile

Follows are private to you and power your alerts

Updated · somnumpharma.com

Sector
Biotech
Headquarters
NEW YORK, NY
Founded
2024
Latest Form D
$2M, Nov 2024
Total capital
$2M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$2M
1 Form D · last Nov 2024
23 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
2 pending

Capital timeline

2024FEDERAL ↑EQUITY ↓Cumulative $2M1st Form D$2M
2024FEDERAL ↑EQUITY ↓Cumulative $2M1st Form D$2M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Michael JasulavicDirectorNamed in SEC Form D filings
  • Orrin DevinskyDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 2
  • PendingCompounds, Compositions, And Methods Of Use ThereofUSPTOApplication PCTUS2025050710
  • PendingCompounds, Compositions, And Methods Of Use ThereofUSPTOApplication 63706327
  • IFM TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • Amide Technologies, Inc.Similar federal contract value in Biotech · null in contracts
  • K36 TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • Solar Biotech, Inc.Similar federal contract value in Biotech · null in contracts
  • Nanomind, Inc.Similar federal contract value in Biotech · null in contracts
  • Quotient TherapeuticsSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .